UK markets closed

Emergent BioSolutions Inc. (0IGA.L)

LSE - LSE Delayed price. Currency in USD
Add to watchlist
1.8500-0.0900 (-4.64%)
At close: 04:19PM BST
Currency in USD

Valuation measures4

Market cap (intra-day) N/A
Enterprise value N/A
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 1.19
52-week change 3-72.60%
S&P500 52-week change 321.61%
52-week high 313.4182
52-week low 31.4800
50-day moving average 32.2403
200-day moving average 34.1333

Share statistics

Avg vol (3-month) 319.43k
Avg vol (10-day) 310.76k
Shares outstanding 550.95M
Implied shares outstanding 6N/A
Float 851.5M
% held by insiders 11.88%
% held by institutions 179.24%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 4N/A
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin -72.48%
Operating margin (ttm)-18.33%

Management effectiveness

Return on assets (ttm)-4.80%
Return on equity (ttm)-74.67%

Income statement

Revenue (ttm)1.05B
Revenue per share (ttm)20.49
Quarterly revenue growth (yoy)-16.20%
Gross profit (ttm)N/A
EBITDA -70.7M
Net income avi to common (ttm)-760.5M
Diluted EPS (ttm)2.9670
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)111.7M
Total cash per share (mrq)2.14
Total debt (mrq)877.5M
Total debt/equity (mrq)135.15%
Current ratio (mrq)1.04
Book value per share (mrq)12.44

Cash flow statement

Operating cash flow (ttm)-206.3M
Levered free cash flow (ttm)-103.41M